PD-L1/B7H-1 inhibits the effector phase of tumor rejection by T cell receptor (TCR) transgenic CD8 T cells (Q28243975)

1

object named as

Christian Blank

0 references

author name string

Ian Brown

2

0 references

Amy C Peterson

3

0 references

Mike Spiotto

4

0 references

Yoshiko Iwai

5

0 references

Thomas F Gajewski

Expression of programmed death 1 ligands by murine T cells and APC

7

0 references

language of work or name

English

0 references

publication date

1 February 2004

0 references

published in

Cancer Research

0 references

volume

64

0 references

issue

3

0 references

page(s)

1140-5

0 references

cites work

1 reference

24 May 2022

https://opencitations.net/index/coci/api/v1/citations/10.4049/JIMMUNOL.169.10.5538

Selective expression of an antigen receptor on CD8-bearing T lymphocytes in transgenic mice

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1158/0008-5472.CAN-03-3259

B7DC/PDL2 promotes tumor immunity by a PD-1-independent mechanism.

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1158/0008-5472.CAN-03-3259

Involvement of PD-L1 on tumor cells in the escape from host immune system and tumor immunotherapy by PD-L1 blockade

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1158/0008-5472.CAN-03-3259

Molecular modeling and functional mapping of B7-H1 and B7-DC uncouple costimulatory function from PD-1 interaction

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1158/0008-5472.CAN-03-3259

Granulocyte-macrophage-colony-stimulating factor added to a multipeptide vaccine for resected Stage II melanoma

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1158/0008-5472.CAN-03-3259

Status of activation of circulating vaccine-elicited CD8 T cells

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1158/0008-5472.CAN-03-3259

PD-L1 and PD-L2 are differentially regulated by Th1 and Th2 cells

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1158/0008-5472.CAN-03-3259

Manipulation of T cell costimulatory and inhibitory signals for immunotherapy of prostate cancer

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1158/0008-5472.CAN-03-3259

PD-1: an inhibitory immunoreceptor involved in peripheral tolerance

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1158/0008-5472.CAN-03-3259

Effects of interleukin-12 on the immune response to a multipeptide vaccine for resected metastatic melanoma

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1158/0008-5472.CAN-03-3259

B7x: a widely expressed B7 family member that inhibits T cell activation

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1158/0008-5472.CAN-03-3259

Increasing tumor antigen expression overcomes "ignorance" to solid tumors via crosspresentation by bone marrow-derived stromal cells

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1158/0008-5472.CAN-03-3259

Tumor-induced immune dysfunction

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1158/0008-5472.CAN-03-3259

Lymphoproliferation in CTLA-4–Deficient Mice Is Mediated by Costimulation-Dependent Activation of CD4 T Cells

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1158/0008-5472.CAN-03-3259

Development of lupus-like autoimmune diseases by disruption of the PD-1 gene encoding an ITIM motif-carrying immunoreceptor

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1158/0008-5472.CAN-03-3259

Cancer regression and autoimmunity in patients after clonal repopulation with antitumor lymphocytes

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1158/0008-5472.CAN-03-3259

PD-1 inhibits antiviral immunity at the effector phase in the liver

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1158/0008-5472.CAN-03-3259

Enhancement of antitumor immunity by CTLA-4 blockade

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1158/0008-5472.CAN-03-3259

Tumor-associated B7-H1 promotes T-cell apoptosis: a potential mechanism of immune evasion

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1158/0008-5472.CAN-03-3259

B7-H1, a third member of the B7 family, co-stimulates T-cell proliferation and interleukin-10 secretion

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1158/0008-5472.CAN-03-3259

Immunization with Melan-A peptide-pulsed peripheral blood mononuclear cells plus recombinant human interleukin-12 induces clinical activity and T-cell responses in advanced melanoma

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1158/0008-5472.CAN-03-3259

Cancer immunoediting: from immunosurveillance to tumor escape

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1158/0008-5472.CAN-03-3259

PD-L2 is a second ligand for PD-1 and inhibits T cell activation

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1158/0008-5472.CAN-03-3259

Improved efficacy of dendritic cell vaccines and successful immunization with tumor antigen peptide-pulsed peripheral blood mononuclear cells by coadministration of recombinant murine interleukin-12

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1158/0008-5472.CAN-03-3259

Autoimmune dilated cardiomyopathy in PD-1 receptor-deficient mice

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1158/0008-5472.CAN-03-3259

Attachment of an anti-receptor antibody to non-target cells renders them susceptible to lysis by a clone of cytotoxic T lymphocytes

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1158/0008-5472.CAN-03-3259

Dendritic Cells as Carriers for a Cytotoxic T-Lymphocyte Epitope-Based Peptide Vaccine in Protection Against a Human Papillomavirus Type 16-Induced Tumor

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1158/0008-5472.CAN-03-3259

Immune inhibitory receptors

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1158/0008-5472.CAN-03-3259

PD-1 immunoreceptor inhibits B cell receptor-mediated signaling by recruiting src homology 2-domain-containing tyrosine phosphatase 2 to phosphotyrosine

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1158/0008-5472.CAN-03-3259

Engagement of the PD-1 immunoinhibitory receptor by a novel B7 family member leads to negative regulation of lymphocyte activation

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1158/0008-5472.CAN-03-3259

Absence of CTLA-4 lowers the activation threshold of primed CD8 TCR-transgenic T cells: lack of correlation with Src homology domain 2-containing protein tyrosine phosphatase

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1158/0008-5472.CAN-03-3259

Regulation of T cell function by NK cell receptors for classical MHC class I molecules.

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1158/0008-5472.CAN-03-3259

BTLA is a lymphocyte inhibitory receptor with similarities to CTLA-4 and PD-1

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1158/0008-5472.CAN-03-3259

Cancer regression and autoimmunity induced by cytotoxic T lymphocyte-associated antigen 4 blockade in patients with metastatic melanoma

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1158/0008-5472.CAN-03-3259

Identifiers

DOI

10.1158/0008-5472.CAN-03-3259

1 reference

stated in

Consolidated OpenCitations Corpus – April 2017

Consolidated OpenCitations Corpus – April 2017

1 reference

stated in

Consolidated OpenCitations Corpus – April 2017

PubMed publication ID

14871849

1 reference

stated in